DT-168 for fuchs' endothelial dystrophy

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 17 Jun 2025: Trial registered, NCT07024693
  2. 30 Jul 2025: Trial started, NCT07024693

The trials

NCT07024693: DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal Dystrophy

State
Under way
Phase
Phase 2
People
70 planned
Started
30 Jul 2025
Primary completion
Dec 2027
Arms
Active
Results
None posted
  1. 17 Jun 2025: Trial registered
  2. 30 Jul 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.